Kevin Li
李凯军
Chairman, MojiaBio
摩珈生物董事长
Dr. Kevin Li, Chairman of MojiaBio, is a distinguished global leader in biotechnology. Under his visionary leadership, MojiaBio has pioneered the conversion of low-cost, renewable carbon sources into high-value chemicals for fragrances, food, and materials. With advanced research and manufacturing facilities in the US, Singapore, and China, the company is at the forefront of specialty chemical production—both through its own bio-manufacturing plant and strategic partnerships with leading industrial players. Dr. Li is driving MojiaBio toward becoming a transformational unicorn in sustainable chemical manufacturing.
Beyond MojiaBio, Dr. Li is also the founder and managing partner of LYZZ Capital, a leading biotech venture capital firm. With over 25 years of entrepreneurial and investment experience across the US and Asia, he has been instrumental in fostering global collaborations and advancing biotech ecosystems. He also serves on the boards of several leading biotech companies in both the US and China.
Dr. Li earned his PhD from Indiana University and completed his postdoctoral fellowship at Stanford University School of Medicine.
李凯军博士是摩珈生物董事长，也是全球生物技术领域具有重要影响力的行业领袖。凭借卓越的战略远见，他带领摩珈生物成功实现了以低成本可再生碳源高效合成高附加值化学品的技术突破，相关产品广泛应用于香料、日化及材料等多个领域。公司在美国、新加坡和中国设有先进的研发与生产基地，不仅依托自有生物制造平台，还通过与多家行业领军企业的战略合作，持续引领特种化学品的创新与生产。李博士正积极推进摩珈生物发展成为可持续化工领域的颠覆性独角兽企业。
此外，李博士也是醴泽资本的创始人及管理合伙人。该机构是一家专注于生物医药领域的领先风险投资基金。凭借在美洲和亚洲市场超过25年的创业与投资经验，他在促进全球产业协作、构建生物技术生态体系方面作出了重要贡献。同时，他还担任多家中美知名生物医药企业的董事职务。
李博士毕业于印第安纳大学，获博士学位，并在斯坦福大学医学院完成博士后研究。
